BioDelivery Sciences (BDSI) Misses Q4 EPS by 18c

BioDelivery Sciences (NASDAQ: BDSI) reported Q4 EPS of ($0.51), $0.18 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $4 million.

For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c